COMMUNIQUÉS West-GlobeNewswire

Olainfarm will hold Fourth Quarter 2017 Investor Conference Webinar
14/03/2018
Olaine, 2018-03-14 11:10 CET (GLOBE NEWSWIRE) -- Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English. During the webinar Salvis Lapiņš will inform about [...]
Curetis Receives USPTO Notice of Allowance for Key Patent Covering Unyvero Technology
14/03/2018
Curetis Receives USPTO Notice of Allowance for Key Patent Covering Unyvero Technology IP position strengthened in the U.S. Patent supports utility of Unyvero Lysator Technology for sample preparation Amsterdam, the [...]
Bio-on launches U-COAT, a company operating in the fertilisers market with a biodegradable controlled-release solution.
14/03/2018
The new company, U-COAT S.p.A. , will sell an innovative solution for the controlled release of Urea fertilisers into the soil. The innovation was developed by Bio-on with PHAs bioplastics, so it is 100% natural and [...]
Kiadis Pharma to Present at the Cowen and Company 38th Annual Health Care Conference
14/03/2018
Kiadis Pharma to Present at the Cowen and Company 38th Annual Health Care Conference Amsterdam, The Netherlands, March 14, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: [...]
DBV Technologies Reports Full Year 2017 Financial Results
14/03/2018
Montrouge, France, March 14, 2018 DBV Technologies Reports Full Year 2017 Financial Results DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced full year 2017 results. Audit [...]
Résultats Financiers 2017 de DBV Technologies
14/03/2018
Montrouge, France, le 14 mars 2018 (7h30 CET) Résultats Financiers 2017 de DBV Technologies DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - NASDAQ : DBVT), société biopharmaceutique française, a annoncé aujourd [...]
Conditions financières améliorées de l'accord entre Nicox et Bausch + Lomb pour VYZULTA
14/03/2018
Communiqué de presse Conditions financières améliorées de l'accord entre Nicox et Bausch + Lomb pour VYZULTA TM Augmentation des redevances de 1% sur les ventes annuelles mondiales de VYZULTA TM dépassant 300 millions [...]
Nicox Announces Improved Financial Terms from Bausch + Lomb for VYZULTA
14/03/2018
Press Release Nicox Announces Improved Financial Terms from Bausch + Lomb for VYZULTA TM Increase in Royalties by 1% on Annual VYZULTA TM Global Sales Revenue Over $300 Million Additional $20 Million in Potential [...]
2017: Tecan with significant increase in sales and profit
14/03/2018
Financial results: full-year and second half of 2017 Order entry of CHF 564.1 million (2016: CHF 503.2 million) Full-year growth of 11.8% in local currencies or 12.1% in Swiss francs Double-digit growth rates in both [...]
Immuron Announces A$5.1M Private Placement to U.S. Fund
13/03/2018
MELBOURNE, Australia, March 13, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ: IMRN ), an Australian microbiome biopharmaceutical company focused on developing and commercializing orally delivered targeted [...]
BioStem Technologies Inc. Announces Engagement of Dr. Felix Amon for Pharmaceutical Business Development
13/03/2018
Pompano Beach, FL, March 13, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a focus in [...]
CORRECTING and REPLACING -- Intercept to Present at Upcoming Conference
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ) please note that the conference date should be March 20, not [...]
Antares Pharma Provides Update Regarding the Cowen and Company 38th Annual Healthcare Conference
13/03/2018
EWING, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) (the Company) today announced that due to the blizzard conditions and lack of travel options present in the greater Boston area, the [...]
Xeris Pharmaceuticals Announces a Formulation Development Collaboration with Asahi Kasei Pharma
13/03/2018
Chicago, March 13, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and [...]
Vericel to Present at the 17th Annual Needham Healthcare Conference
13/03/2018
CAMBRIDGE, Mass., March 13, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, [...]
Intercept to Present at Upcoming Conference
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
Sienna Senior Living Inc. Added to S&P/TSX Composite Index
13/03/2018
MARKHAM, Ontario, March 13, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) is pleased to announce that it will be added to the S&P/TSX Composite Index effective March [...]
Rockwell Medical, Inc. Appoints Two Independent and Experienced Life Sciences Executives to Board of Directors
13/03/2018
Lisa Colleran and Benjamin Wolin Unanimously Appointed to Rockwell Board Wolin Named Chairman of the Board Company Reaches Support Agreement with Richmond Brothers WIXOM, Mich., March 13, 2018 (GLOBE NEWSWIRE) -- [...]
Melinta Therapeutics Cancels Presentation at The Cowen & Company 38th Annual Health Care Conference Due to Inclement Weather
13/03/2018
NEW HAVEN, Conn., March 13, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, [...]

Pages